2015
DOI: 10.1038/ng.3335
|View full text |Cite
|
Sign up to set email alerts
|

CTCF/cohesin-binding sites are frequently mutated in cancer

Abstract: Cohesin is present in almost all active enhancer regions, where it is associated with transcription factors. Cohesin frequently colocalizes with CTCF (CCCTC-binding factor), affecting genomic stability, expression and epigenetic homeostasis. Cohesin subunits are mutated in cancer, but CTCF/cohesin-binding sites (CBSs) in DNA have not been examined for mutations. Here we report frequent mutations at CBSs in cancers displaying a mutational signature where mutations in A•T base pairs predominate. Integration of w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

29
396
3

Year Published

2016
2016
2020
2020

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 383 publications
(428 citation statements)
references
References 29 publications
29
396
3
Order By: Relevance
“…In general, the number of such mutations ranges from a few hundred (as found in some types of paediatric cancer) to more than a million (in hypermutator forms of colon and endometrial cancer) [98][99][100] . Oncogenic driver mutations in this category can be genetically identified by comparing their observed occurrence with that expected from the background mutation rate.…”
Section: Somatic Non-coding Mutations In Enhancersmentioning
confidence: 99%
See 1 more Smart Citation
“…In general, the number of such mutations ranges from a few hundred (as found in some types of paediatric cancer) to more than a million (in hypermutator forms of colon and endometrial cancer) [98][99][100] . Oncogenic driver mutations in this category can be genetically identified by comparing their observed occurrence with that expected from the background mutation rate.…”
Section: Somatic Non-coding Mutations In Enhancersmentioning
confidence: 99%
“…As a consequence, the number of recurrent mutations in the non-coding genome that have been identified so far is small. For example, unbiased analysis of mutations in the whole genome of colorectal cancer and CLL cells easily picks up mutational hot spots in known oncogenes and tumour suppressor genes, but fails to identify large numbers of recurrently mutated non-coding elements 99,101 . These data indicate either that non-coding driver mutations are relatively rare in cancer or that they are spread across a large number of different regulatory elements.…”
Section: Somatic Non-coding Mutations In Enhancersmentioning
confidence: 99%
“…More generally, mutations in individual CTCF sites can lead to loss of binding and disruption of loop formation, with important consequences for disease susceptibility. CTCF-binding sites are major hot spots for mutations in the cancer genome (Katainen et al 2015), and oncogenes can be activated by mutations that disrupt CTCF binding at the boundaries of loop domains ).…”
Section: Dna Methylation and Ctcf Bindingmentioning
confidence: 99%
“…TADs partition chromosomes into blocks of DNA at scales of hundreds of kilobases to megabases of DNA and are frequently bounded at inverted CTCF-binding sites, suggesting that CTCF-mediated loops comprise a major organizing principle for the genome (Cook and Gove 1992;Dekker and Heard 2015;Dekker and Misteli 2015;Dixon et al 2012;Guo et al 2015;Ji et al 2016;Pope et al 2014;Smith et al 2016;Tang et al 2015;Valton and Dekker 2016). CTCF and cohesin are enriched at TAD boundaries (Guo et al 2015;Ji et al 2016;Katainen et al 2015;Rao et al 2015;Sofueva et al 2013;Tang et al 2015;Xiao et al 2011;Zuin et al 2014). The requirement for inverted CTCF sites is perplexing (Guo et al 2015;Rao et al 2014;Rao et al 2015); loops occurring on this scale would be expected to include many statistical segments and therefore to be insensitive to CTCF-site orientation.…”
Section: Intranuclear Topology Topography and Cartographymentioning
confidence: 99%